Author(s) |
(Date) |
Paper Title |
Citation |
Model Type |
Applications |
Full Text |
| Tian J, et al. Mouse over for full list |
(2022) | Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases-The Case for Using Ignored Target Cell Antigen Determinants. | Cells 11(7) | Autoimmune, Diabetes (Type 1), Immunotherapy | ||
| Simecek P, et al. Mouse over for full list |
(2015) | Genetic Analysis of Substrain Divergence in Non-Obese Diabetic (NOD) Mice. | G3 (Bethesda) 5(5):771-5 | |||
| Hsueh PY, et al. Mouse over for full list |
(2020) | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye. | Int J Mol Sci 21(8) | |||
| Mattner J, et al. Mouse over for full list |
(2019) | Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice. | PLoS Genet. 15(6):e1008178 | Diabetes (Type 1) | ||
| Neuman V, et al. Mouse over for full list |
(2019) | Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor. | Diabetologia | Diabetes (Type 1), Microbiome | ||
| Washburn LR, et al. Mouse over for full list |
(2007) | The postnatal maternal environment influences diabetes development in nonobese diabetic mice. | J. Autoimmun. 28(1):19-23 | |||
| Tracy S, et al. Mouse over for full list |
(2002) | Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. | J. Virol. 76(23):12097-111 | |||
| Tian C, et al. Mouse over for full list |
(2004) | Prevention of type 1 diabetes by gene therapy. | J. Clin. Invest. 114(7):969-78 | Diabetes (Type 1) | ||
| Swyers J Mouse over for full list |
(2007) | Antibody therapy prevents type 1 diabetes in mice | ||||
| Ryu S, et al. Mouse over for full list |
(2001) | Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. | J. Clin. Invest. 108(1):63-72 | |||
| Mabley JG, et al. Mouse over for full list |
(2003) | Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. | Mol. Med. 9(3-4):96-104 | Diabetes (Type 1) | ||
| Liu E, et al. Mouse over for full list |
(2002) | Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. | J. Clin. Invest. 110(7):1021-7 | |||
| Irie J, et al. Mouse over for full list |
(2007) | Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. | Diabetes 56(1):186-96 | Diabetes (Type 1) | ||
| Homo-Delarche F Mouse over for full list |
(2004) | Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse. | ILAR J 45(3):237-58 | |||
| Goudy K, et al. Mouse over for full list |
(2001) | Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. | Proc. Natl. Acad. Sci. U.S.A. 98(24):13913-8 | Diabetes (Type 1) | ||
| Gordon EJ, et al. Mouse over for full list |
(2005) | Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice. | Diabetes 54(1):107-15 | |||
| Fife BT, et al. Mouse over for full list |
(2006) | Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. | J. Clin. Invest. 116(8):2252-61 | T And/Or B Cell Function | ||
| da Costa SR, et al. Mouse over for full list |
(2006) | Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. | Exp. Eye Res. 82(1):33-45 | |||
| Bour-Jordan H, et al. Mouse over for full list |
(2004) | Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. | J. Clin. Invest. 114(7):979-87 | |||
| Bergerot I, et al. Mouse over for full list |
(1997) | A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. | Proc. Natl. Acad. Sci. U.S.A. 94(9):4610-4 | |||
| Basso AS, et al. Mouse over for full list |
(2008) | Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. | J. Clin. Invest. 118(4):1532-43 | |||
| Atkinson MA, et al. Mouse over for full list |
(1999) | The NOD mouse model of type 1 diabetes: as good as it gets? | Nat. Med. 5(6):601-4 | Diabetes (Type 1) | ||
| Bothe GW, et al. Mouse over for full list |
(2005) | Behavioral differences among fourteen inbred mouse strains commonly used as disease models. | Comp. Med. 55(4):326-34 | Behavior |
Welcome! Tell us a little about yourself